SynapDx wins funds to advance development of autism test

07/23/2013 | American City Business Journals

A funding round headed by Google Ventures has pulled in $15.4 million for SynapDx. The Lexington, Mass.-based startup, which specializes in pediatric genomics, will use the money to further develop its blood-based assay for the early detection of autism spectrum disorder in children.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD